Sfoglia per Rivista
NODAL AND NON-NODAL MANTLE CELL LYMPHOMAS DISPLAY A DIFFERENT GENOMIC PROFILE AND IGHV MUTATIONAL STATUS
2010 DEL GIUDICE, Ilaria; Messina, M.; Chiaretti, Sabina; Santangelo, S.; Tavolaro, S.; Maria Stefania De Propris, ; Nanni, M.; Pescarmona, Edoardo; Mancini, F.; Pulsoni, A.; Russo, E.; Cavalieri, E.; Finolezzi, E.; Cuneo, A.; Mauro, F.; Guarini, A.; Foa, R.
NOTCH1 mutations in+12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of+12 CLL
2012 DEL GIUDICE, Ilaria; D., Rossi; Chiaretti, Sabina; M., Marinelli; Tavolaro, Simona; S., Gabrielli; L., Laurenti; R., Marasca; S., Rasi; M., Fangazio; Guarini, Anna; G., Gaidano; Foa, Roberto
NOTCH3: A MORE PROMINENT PLAYER THAN NOTCH1 IN THE PATHOGENESIS OF T-ALL?
2010 E., Radwan; Ferretti, Elisabetta; Checquolo, Saula; Grazioli, Paola; Talora, Claudio; H., Moussa; Campese, Antonio Francesco; M., El Ansary; S., Hussein; D., Yassin; A., Kamel; Screpanti, Isabella
Novel Histone Deacetilase (HDAC) inhibitors: in vitro effects on leukemic cells.
2012 Licchetta, R; Ricciardi, Maria Rosaria; Bergamo, P; Mirabilii, Simone; Iacovelli, S; Allegretti, Matteo; Petrucci, Mt; Milella, M; Pisano, C; Tafuri, Agostino
Novel Histone Deacetylase (HDAC) inhibitors: in vitro effects on leukemic cells
2013 Licchetta, Roberto; Ricciardi, Maria Rosaria; Mirabilii, Simone; Allegretti, Matteo; M., Vincenzi; G., Giannini; C., Pisano; L., Vesci; Tafuri, Agostino
Novel kinase inhibitors afuresertib and PIM447 are active alone and in combination with standard therapies, respectively, in a predictive MM in vivo model, and a CRISPR genome-wide screening approach identifies clinically-relevant biomarkers determining susceptibility to these therapeutic strategies
2018 N, Keane; Natoni, Alessandro; M, Sharik; M, Chesi; Pl, Bergsagel; M, O'Dwyer
Novel therapeutic approaches in elderly acute myeloid leukemia patients: topotecan and CMA-676
2000 Tafuri, Agostino
Obesity is a risk factor for acute promyelocytic leukemia: evidence from population and cross-sectional studies and correlation with FLT3 mutations and polyunsaturated fatty acid metabolism
2020 Mazzarella, Luca; Botteri, Edoardo; Matthews, Anthony; Gatti, Elena; Di Salvatore, Davide; Bagnardi, Vincenzo; Breccia, Massimo; Montesinos, Pau; Bernal, Teresa; Gil, Cristina; J Ley, Timothy; Sanz, Miguel; Bhaskaran, Krishnan; LO COCO, Francesco; Giuseppe Pelicci, Pier
Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice
2019 Fava, Carmen; Rege-Cambrin, Giovanna; Dogliotti, Irene; Cerrano, Marco; Berchialla, Paola; Dragani, Matteo; Rosti, Gianantonio; Castagnetti, Fausto; Gugliotta, Gabriele; Martino, Bruno; Gambacorti-Passerini, Carlo; Abruzzese, Elisabetta; Elena, Chiara; Pregno, Patrizia; Gozzini, Antonella; Capodanno, Isabella; Bergamaschi, Micaela; Crugnola, Monica; Bocchia, Monica; Galimberti, Sara; Rapezzi, Davide; Iurlo, Alessandra; Cattaneo, Daniele; Latagliata, Roberto; Breccia, Massimo; Cedrone, Michele; Santoro, Marco; Annunziata, Mario; Levato, Luciano; Stagno, Fabio; Cavazzini, Francesco; Sgherza, Nicola; Giai, Valentina; Luciano, Luigia; Russo, Sabina; Musto, Pellegrino; Caocci, Giovanni; Sora, Federica; Iuliano, Francesco; Lunghi, Francesca; Specchia, Giorgina; Pane, Fabrizio; Ferrero, Dario; Baccarani, Michele; Saglio, Giuseppe
OCCURRENCE OF PLEURAL EFFUSIONS DURING DASATINIB TREATMENT IN ELDERLY CHRONIC MYELOGENOUS LEUKEMIA PATIENTS
2009 Latagliata, R.; Breccia, M; Stagno, F.; Luciano, L.; Gozzini, A.; Annunziata, M.; De Matteis, S.; Albano, F.; Ulisciani, S.; Pregno, P.; Pacilli, M.; Abruzzese, E.; Martino, B.; Tiribelli, M.; Avanzini, P; Pacilli, L.; Vigneri, P.; Fabbricini, R; Russo Rossi, A.; Sica, S.; Vitolo, U.; Montefusco, E.; Fava, C.; Ferrara, F.; Santini, V.; Pane, F.; Di Raimondo, F.; Alimena, G
OCCURRENCE OF PLEURAL EFFUSIONS DURING DASATINIB TREATMENT IN ELDERLY CML PATIENTS
2010 Latagliata, R; Breccia, M; Vigneri, P; Luciano, L; Gozzini, A; Castagnetti, F; Ulisciani, S; Cavazzini, F; Annunziata, M; Sorà, F; Russo Rossi, A; Pregno, P; Porrini, R; Trawinska, M; Crisà, E; Musto, P; Tiribelli, M; Binotto, G; Occhini, U; Feo, C; Martino, B; Avanzini, P; Spina, E; Pane, F; Santini, V; Rosti, G; Rege Cambrin, G; Alimena, G
Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia
2019 Steurer, Michael; Montillo, Marco; Scarfò, Lydia; Mauro, Francesca R; Andel, Johannes; Wildner, Sophie; Trentin, Livio; Janssens, Ann; Burgstaller, Sonja; Frömming, Anna; Dümmler, Thomas; Riecke, Kai; Baumann, Matthias; Beyer, Diana; Vauléon, Stéphanie; Ghia, Paolo; Foà, Robin; Caligaris-Cappio, Federico; Gobbi, Marco
One year cyclosporine prophylacsis reduces the risk of devoloping extensive chronic graft versus host disease after allogenic peripheral blood stem cell transplantantion
2003 Mengarelli, A.; Iori, A. P.; Romano, A.; Cerretti, R.; Cerilli, L.; DE PROPRIS, M. S.; Fenu, S.; Moleti, M. L.; DE FELICE, L.; Girelli, Gabriella; Arcese, W.
ORAL SEAWEED CALCIUM DERIVED FROM LITHOTHAMNION IS SAFE AND EFFECTIVE AND WELL TOLERATED AS ORAL LACTATE-GLUCONATE AND CARBONATE CALCIUM IN TUMOR LYSIS SYNDROME WITH RENAL FAILURE AND WATER OVERLOAD
2012 Giordano, G; Tambaro, R; Perrotta, N; D'Amico, F; Sticca, G; Di Falco, C; Mondello, P
Out-patient management of acute myeloid leukemia after consolidation chemotherapy. Role of a hematologic emergency unit
1999 C., Girmenia; Alimena, Giuliana; R., Latagliata; S. G., Morano; F., Celesti; L., Coppola; A., Spadea; S., Tosti; S., Mecarocci; G. M., D'Elia; Tafuri, Agostino; Cimino, Giuseppe; Mandelli, Franco
The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: A report from the Italian Pediatric Group
2007 Locatelli, F.; Zecca, M.; Pession, A.; Morreale, G.; Longoni, D.; Di Bartolomeo, P.; Porta, F.; Fagioli, F.; Nobili, B.; Bernardo, M. E.; Messina, C.
OUTCOME OF PATIENTS WITH CHRONIC PHASE CML TREATED WITH DASATINIB OR NILOTINIB AFTER FAILURE OF SECOND PRIOR TKIS
2011 Russo Rossi, A; Castagnetti, F; Breccia, M; Luciano, L; Gozzini, A; Annunziata, M; Martino, B; Stagno, F; Cavazzini, F; Tiribelli, M; Visani, G; Pregno, P; Musto, P; Fava, C; Avanzini, P; Turri, D; Porretto, F; Abruzzese, E; Sgherza, N; Albano, F; Specchia, G
Outcome of very late relapse in children with acute lymphoblastic leukemia
2004 Rizzari, C.; Valsecchi, M. G.; Arico, M.; Miniero, R.; Messina, C.; De Rossi, G.; Testi, Anna Maria; Mura, R.; Galimberti, S.; Biondi, A.; Locatelli, F.; Conter, V.
Outcomes of children and young adults with B-cell acute lymphoblastic leukemia given blinatumomab as last consolidation treatment before allogeneic hematopoietic stem cell transplantation
2024 Algeri, Mattia; Massa, Michele; Pagliara, Daria; Bertaina, Valentina; Galaverna, Federica; Pili, Ilaria; Li Pira, Giuseppina; Carta, Roberto; Quagliarella, Francesco; Pinto, Rita M.; Rosignoli, Chiara; Lucarelli, Barbarella; Cefalo, Maria G.; Boccieri, Emilia; Benini, Francesca; Del Bufalo, Francesca; Becilli, Marco; Merli, Pietro; Zugmaier, Gerhard; Locatelli, Franco
OVEREXPRESSION OF FBP1 IS ASSOCIATED TO HIGH SOKAL RISK IN CHRONIC MYELOID LEUKEMIA PATIENTS
2011 Durante, S; Terragna, C; Astolfi, A; Palandri, F; Castagnetti, F; Testoni, N; Amabile, M; Iacobucci, I; Soverini, S; Alimena, G; Breccia, M; Pane, F; Saglio, G; Rosti, G; Baccarani, M; Martinelli, G
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| NODAL AND NON-NODAL MANTLE CELL LYMPHOMAS DISPLAY A DIFFERENT GENOMIC PROFILE AND IGHV MUTATIONAL STATUS | 2010 | DEL GIUDICE, Ilaria; Messina, M.; Chiaretti, Sabina; Santangelo, S.; Tavolaro, S.; Maria Stefania De Propris, ; Nanni, M.; Pescarmona, Edoardo; Mancini, F.; Pulsoni, A.; Russo, E.; Cavalieri, E.; Finolezzi, E.; Cuneo, A.; Mauro, F.; Guarini, A.; Foa, R. | |
| NOTCH1 mutations in+12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of+12 CLL | 2012 | DEL GIUDICE, Ilaria; D., Rossi; Chiaretti, Sabina; M., Marinelli; Tavolaro, Simona; S., Gabrielli; L., Laurenti; R., Marasca; S., Rasi; M., Fangazio; Guarini, Anna; G., Gaidano; Foa, Roberto | |
| NOTCH3: A MORE PROMINENT PLAYER THAN NOTCH1 IN THE PATHOGENESIS OF T-ALL? | 2010 | E., Radwan; Ferretti, Elisabetta; Checquolo, Saula; Grazioli, Paola; Talora, Claudio; H., Moussa; Campese, Antonio Francesco; M., El Ansary; S., Hussein; D., Yassin; A., Kamel; Screpanti, Isabella | |
| Novel Histone Deacetilase (HDAC) inhibitors: in vitro effects on leukemic cells. | 2012 | Licchetta, R; Ricciardi, Maria Rosaria; Bergamo, P; Mirabilii, Simone; Iacovelli, S; Allegretti, Matteo; Petrucci, Mt; Milella, M; Pisano, C; Tafuri, Agostino | |
| Novel Histone Deacetylase (HDAC) inhibitors: in vitro effects on leukemic cells | 2013 | Licchetta, Roberto; Ricciardi, Maria Rosaria; Mirabilii, Simone; Allegretti, Matteo; M., Vincenzi; G., Giannini; C., Pisano; L., Vesci; Tafuri, Agostino | |
| Novel kinase inhibitors afuresertib and PIM447 are active alone and in combination with standard therapies, respectively, in a predictive MM in vivo model, and a CRISPR genome-wide screening approach identifies clinically-relevant biomarkers determining susceptibility to these therapeutic strategies | 2018 | N, Keane; Natoni, Alessandro; M, Sharik; M, Chesi; Pl, Bergsagel; M, O'Dwyer | |
| Novel therapeutic approaches in elderly acute myeloid leukemia patients: topotecan and CMA-676 | 2000 | Tafuri, Agostino | |
| Obesity is a risk factor for acute promyelocytic leukemia: evidence from population and cross-sectional studies and correlation with FLT3 mutations and polyunsaturated fatty acid metabolism | 2020 | Mazzarella, Luca; Botteri, Edoardo; Matthews, Anthony; Gatti, Elena; Di Salvatore, Davide; Bagnardi, Vincenzo; Breccia, Massimo; Montesinos, Pau; Bernal, Teresa; Gil, Cristina; J Ley, Timothy; Sanz, Miguel; Bhaskaran, Krishnan; LO COCO, Francesco; Giuseppe Pelicci, Pier | |
| Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice | 2019 | Fava, Carmen; Rege-Cambrin, Giovanna; Dogliotti, Irene; Cerrano, Marco; Berchialla, Paola; Dragani, Matteo; Rosti, Gianantonio; Castagnetti, Fausto; Gugliotta, Gabriele; Martino, Bruno; Gambacorti-Passerini, Carlo; Abruzzese, Elisabetta; Elena, Chiara; Pregno, Patrizia; Gozzini, Antonella; Capodanno, Isabella; Bergamaschi, Micaela; Crugnola, Monica; Bocchia, Monica; Galimberti, Sara; Rapezzi, Davide; Iurlo, Alessandra; Cattaneo, Daniele; Latagliata, Roberto; Breccia, Massimo; Cedrone, Michele; Santoro, Marco; Annunziata, Mario; Levato, Luciano; Stagno, Fabio; Cavazzini, Francesco; Sgherza, Nicola; Giai, Valentina; Luciano, Luigia; Russo, Sabina; Musto, Pellegrino; Caocci, Giovanni; Sora, Federica; Iuliano, Francesco; Lunghi, Francesca; Specchia, Giorgina; Pane, Fabrizio; Ferrero, Dario; Baccarani, Michele; Saglio, Giuseppe | |
| OCCURRENCE OF PLEURAL EFFUSIONS DURING DASATINIB TREATMENT IN ELDERLY CHRONIC MYELOGENOUS LEUKEMIA PATIENTS | 2009 | Latagliata, R.; Breccia, M; Stagno, F.; Luciano, L.; Gozzini, A.; Annunziata, M.; De Matteis, S.; Albano, F.; Ulisciani, S.; Pregno, P.; Pacilli, M.; Abruzzese, E.; Martino, B.; Tiribelli, M.; Avanzini, P; Pacilli, L.; Vigneri, P.; Fabbricini, R; Russo Rossi, A.; Sica, S.; Vitolo, U.; Montefusco, E.; Fava, C.; Ferrara, F.; Santini, V.; Pane, F.; Di Raimondo, F.; Alimena, G | |
| OCCURRENCE OF PLEURAL EFFUSIONS DURING DASATINIB TREATMENT IN ELDERLY CML PATIENTS | 2010 | Latagliata, R; Breccia, M; Vigneri, P; Luciano, L; Gozzini, A; Castagnetti, F; Ulisciani, S; Cavazzini, F; Annunziata, M; Sorà, F; Russo Rossi, A; Pregno, P; Porrini, R; Trawinska, M; Crisà, E; Musto, P; Tiribelli, M; Binotto, G; Occhini, U; Feo, C; Martino, B; Avanzini, P; Spina, E; Pane, F; Santini, V; Rosti, G; Rege Cambrin, G; Alimena, G | |
| Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia | 2019 | Steurer, Michael; Montillo, Marco; Scarfò, Lydia; Mauro, Francesca R; Andel, Johannes; Wildner, Sophie; Trentin, Livio; Janssens, Ann; Burgstaller, Sonja; Frömming, Anna; Dümmler, Thomas; Riecke, Kai; Baumann, Matthias; Beyer, Diana; Vauléon, Stéphanie; Ghia, Paolo; Foà, Robin; Caligaris-Cappio, Federico; Gobbi, Marco | |
| One year cyclosporine prophylacsis reduces the risk of devoloping extensive chronic graft versus host disease after allogenic peripheral blood stem cell transplantantion | 2003 | Mengarelli, A.; Iori, A. P.; Romano, A.; Cerretti, R.; Cerilli, L.; DE PROPRIS, M. S.; Fenu, S.; Moleti, M. L.; DE FELICE, L.; Girelli, Gabriella; Arcese, W. | |
| ORAL SEAWEED CALCIUM DERIVED FROM LITHOTHAMNION IS SAFE AND EFFECTIVE AND WELL TOLERATED AS ORAL LACTATE-GLUCONATE AND CARBONATE CALCIUM IN TUMOR LYSIS SYNDROME WITH RENAL FAILURE AND WATER OVERLOAD | 2012 | Giordano, G; Tambaro, R; Perrotta, N; D'Amico, F; Sticca, G; Di Falco, C; Mondello, P | |
| Out-patient management of acute myeloid leukemia after consolidation chemotherapy. Role of a hematologic emergency unit | 1999 | C., Girmenia; Alimena, Giuliana; R., Latagliata; S. G., Morano; F., Celesti; L., Coppola; A., Spadea; S., Tosti; S., Mecarocci; G. M., D'Elia; Tafuri, Agostino; Cimino, Giuseppe; Mandelli, Franco | |
| The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: A report from the Italian Pediatric Group | 2007 | Locatelli, F.; Zecca, M.; Pession, A.; Morreale, G.; Longoni, D.; Di Bartolomeo, P.; Porta, F.; Fagioli, F.; Nobili, B.; Bernardo, M. E.; Messina, C. | |
| OUTCOME OF PATIENTS WITH CHRONIC PHASE CML TREATED WITH DASATINIB OR NILOTINIB AFTER FAILURE OF SECOND PRIOR TKIS | 2011 | Russo Rossi, A; Castagnetti, F; Breccia, M; Luciano, L; Gozzini, A; Annunziata, M; Martino, B; Stagno, F; Cavazzini, F; Tiribelli, M; Visani, G; Pregno, P; Musto, P; Fava, C; Avanzini, P; Turri, D; Porretto, F; Abruzzese, E; Sgherza, N; Albano, F; Specchia, G | |
| Outcome of very late relapse in children with acute lymphoblastic leukemia | 2004 | Rizzari, C.; Valsecchi, M. G.; Arico, M.; Miniero, R.; Messina, C.; De Rossi, G.; Testi, Anna Maria; Mura, R.; Galimberti, S.; Biondi, A.; Locatelli, F.; Conter, V. | |
| Outcomes of children and young adults with B-cell acute lymphoblastic leukemia given blinatumomab as last consolidation treatment before allogeneic hematopoietic stem cell transplantation | 2024 | Algeri, Mattia; Massa, Michele; Pagliara, Daria; Bertaina, Valentina; Galaverna, Federica; Pili, Ilaria; Li Pira, Giuseppina; Carta, Roberto; Quagliarella, Francesco; Pinto, Rita M.; Rosignoli, Chiara; Lucarelli, Barbarella; Cefalo, Maria G.; Boccieri, Emilia; Benini, Francesca; Del Bufalo, Francesca; Becilli, Marco; Merli, Pietro; Zugmaier, Gerhard; Locatelli, Franco | |
| OVEREXPRESSION OF FBP1 IS ASSOCIATED TO HIGH SOKAL RISK IN CHRONIC MYELOID LEUKEMIA PATIENTS | 2011 | Durante, S; Terragna, C; Astolfi, A; Palandri, F; Castagnetti, F; Testoni, N; Amabile, M; Iacobucci, I; Soverini, S; Alimena, G; Breccia, M; Pane, F; Saglio, G; Rosti, G; Baccarani, M; Martinelli, G |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile